3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
CNS
1
Conditions
Oligodendroglioma
1
Gliosarcoma
1
Glioblastoma
1
Ependymoma
1
Astrocytoma
1
Interventions
Temozolomide
4
Surgical Procedures, Operative
2
Radiotherapy
2
Magnetic Resonance Spectroscopy
2
Gadolinium DTPA
2
Filgrastim
2
Erlotinib Hydrochloride
2
Congresses as Topic
2
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole
2
vitespin
1
sargramostim
1
picropodophyllin
1
marizomib
1
imetelstat
1
gadobutrol
1
gadobenic acid
1
fluorodopa F 18
1
bempegaldesleukin
1
antineoplaston AS 2-1
1
antineoplaston A10
1
Yoga
1
Transurethral Resection of Bladder
1
Topotecan
1
Thiotepa
1
Ritonavir
1
Radiation
1
Peripheral Blood Stem Cell Transplantation
1
Perfusion Magnetic Resonance Imaging
1
O(6)-benzylguanine
1
Nivolumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Ependymoma
×
picropodophyllin
×
Clear all
NCT01721577
2023-05-22
AXL1717
Rush University Medical Center
Phase 1/2
Terminated
10 enrolled
8 charts